Search

everythinglearnresearchcommunity

for

Search:↓

Both genetic and lifestyle factors significantly affect female hair loss.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Removing part of the vitamin D receptor stops vitamin D from working properly.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Overweight women with PCOS are more likely to have excess male hormones.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Hair loss in women not always linked to increased oil production; other factors may be involved.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.